MTR and neoplasm: Moreover, CAR-Ms are enriched with PI3K-AKT signaling pathways, antigen processing and presentation, and chemokine signaling pathways, suggesting that multiple anti-tumor mechanisms of CAR-M contribute to its phagocytic and cytotoxic effects on tumors (Fig. 3B, Fig. S4).